Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 8589318, 14 pages
http://dx.doi.org/10.1155/2016/8589318
Review Article

Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers

Tao Zuo,1,2,3 Minghui Zhu,4 and Wenming Xu1,3

1Joint Laboratory of Reproductive Medicine, SCU-CUHK, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China
2Department of Biological and Pharmaceutical Engineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, China
3Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China
4Reproductive Medicine Center, The Second Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China

Received 22 June 2015; Revised 28 August 2015; Accepted 6 September 2015

Academic Editor: Sahdeo Prasad

Copyright © 2016 Tao Zuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Joham, H. J. Teede, S. Ranasinha, S. Zoungas, and J. Boyle, “Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study,” Journal of Women's Health, vol. 24, no. 4, pp. 299–307, 2015. View at Publisher · View at Google Scholar
  2. A. Chereau, Mémoires pour Servir à l'Étude des Maladies des Ovaires, Fortin, Masson, Paris, France, 1844.
  3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS),” Human Reproduction, vol. 19, no. 1, pp. 41–47, 2004. View at Google Scholar
  4. M. Murri, M. Luque-ramírez, M. Insenser, M. Ojeda-ojeda, and H. F. Escobar-morreale, “Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis,” Human Reproduction Update, vol. 19, no. 3, Article ID dms059, pp. 268–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zhang, P. Fan, H. Liu, H. Bai, Y. Wang, and F. Zhang, “Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS,” Human Reproduction, vol. 27, no. 8, pp. 2484–2493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Lim, M. J. Davies, R. J. Norman, and L. J. Moran, “Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis,” Human Reproduction Update, vol. 18, no. 6, Article ID dms030, pp. 618–637, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. C. M. de Groot, O. M. Dekkers, J. A. Romijn, S. W. M. Dieben, and F. M. Helmerhorst, “PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis,” Human Reproduction Update, vol. 17, no. 4, Article ID dmr001, pp. 495–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Moran, M. L. Misso, R. A. Wild, and R. J. Norman, “Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis,” Human Reproduction Update, vol. 16, no. 4, pp. 347–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Nasiri, A. Moini, P. Eftekhari-Yazdi et al., “Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 184, pp. 112–116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Savic-Radojevic, I. Bozic Antic, V. Coric et al., “Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome,” Hormone, vol. 14, no. 1, pp. 101–108, 2015. View at Publisher · View at Google Scholar
  11. F. González, K. Sreekumaran Nair, J. K. Daniels, E. Basal, and J. M. Schimke, “Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women,” American Journal of Physiology—Endocrinology and Metabolism, vol. 302, no. 3, pp. E297–E306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Federico, F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio, “Chronic inflammation and oxidative stress in human carcinogenesis,” International Journal of Cancer, vol. 121, no. 11, pp. 2381–2386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Balen, “Polycystic ovary syndrome and cancer,” Human Reproduction Update, vol. 7, no. 6, pp. 522–525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Dumesic and R. A. Lobo, “Cancer risk and PCOS,” Steroids, vol. 78, no. 8, pp. 782–785, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. N. Fader, L. N. Arriba, H. E. Frasure, and V. E. von Gruenigen, “Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship,” Gynecologic Oncology, vol. 114, no. 1, pp. 121–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Hardiman, O. S. Pillay, and W. Atiomo, “Polycystic ovary syndrome and endometrial carcinoma,” The Lancet, vol. 361, no. 9371, pp. 1810–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Navaratnarajah, O. C. Pillay, and P. Hardiman, “Polycystic ovary syndrome and endometrial cancer,” Seminars in Reproductive Medicine, vol. 26, no. 1, pp. 62–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. N. Shafiee, C. Chapman, D. Barrett, J. Abu, and W. Atiomo, “Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?” Gynecologic Oncology, vol. 131, no. 2, pp. 489–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Halliwell, “Oxidative stress and cancer: have we moved forward?” Biochemical Journal, vol. 401, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Krstić, D. Trivanović, S. Mojsilović, and J. F. Santibanez, “Transforming growth factor-beta and oxidative stress interplay: implications in tumorigenesis and cancer progression,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 654594, 15 pages, 2015. View at Publisher · View at Google Scholar
  21. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Ziech, R. Franco, A. Pappa, and M. I. Panayiotidis, “Reactive Oxygen Species (ROS)—Induced genetic and epigenetic alterations in human carcinogenesis,” Mutation Research, vol. 711, no. 1-2, pp. 167–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Lebedeva, J. S. Eaton, and G. S. Shadel, “Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1787, no. 5, pp. 328–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Bartsch and J. Nair, “Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair,” Langenbeck's Archives of Surgery, vol. 391, no. 5, pp. 499–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. V. Donkena, C. Y. F. Young, and D. J. Tindall, “Oxidative stress and DNA methylation in prostate cancer,” Obstetrics and Gynecology International, vol. 2010, Article ID 302051, 14 pages, 2010. View at Publisher · View at Google Scholar
  26. R. Franco, O. Schoneveld, A. G. Georgakilas, and M. I. Panayiotidis, “Oxidative stress, DNA methylation and carcinogenesis,” Cancer Letters, vol. 266, no. 1, pp. 6–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Pisoschi and A. Pop, “The role of antioxidants in the chemistry of oxidative stress: a review,” European Journal of Medicinal Chemistry, vol. 97, pp. 55–74, 2015. View at Publisher · View at Google Scholar
  28. R. De Bont and N. van Larebeke, “Endogenous DNA damage in humans: a review of quantitative data,” Mutagenesis, vol. 19, no. 3, pp. 169–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Hiraku and S. Kawanishi, “Immunohistochemical analysis of 8-nitroguanine, a nitrative DNA lesion, in relation to inflammation-associated carcinogenesis,” Methods in Molecular Biology, vol. 512, pp. 3–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo, “Protein carbonyl groups as biomarkers of oxidative stress,” Clinica Chimica Acta, vol. 329, no. 1-2, pp. 23–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Dalle-Donne, D. Giustarini, R. Colombo, R. Rossi, and A. Milzani, “Protein carbonylation in human diseases,” Trends in Molecular Medicine, vol. 9, no. 4, pp. 169–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, “Biomarkers of oxidative damage in human disease,” Clinical Chemistry, vol. 52, no. 4, pp. 601–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Tezil and H. Basaga, “Modulation of cell death in age-related diseases,” Current Pharmaceutical Design, vol. 20, no. 18, pp. 3052–3067, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Halliwell, J. M. C. Gutteridge, and C. E. Cross, “Free radicals, antioxidants, and human disease: where are we now?” The Journal of Laboratory and Clinical Medicine, vol. 119, no. 6, pp. 598–620, 1992. View at Google Scholar · View at Scopus
  35. P. A. Riley, “Free radicals in biology: oxidative stress and the effects of ionizing radiation,” International Journal of Radiation Biology, vol. 65, no. 1, pp. 27–33, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. C. Gutteridge, “Biological origin of free radicals, and mechanisms of antioxidant protection,” Chemico-Biological Interactions, vol. 91, no. 2-3, pp. 133–140, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. H. N. Siti, Y. Kamisah, and J. Kamsiah, “The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review),” Vascular Pharmacology, vol. 71, pp. 40–56, 2015. View at Publisher · View at Google Scholar
  38. N. C. Brown, A. C. Andreazza, and L. T. Young, “An updated meta-analysis of oxidative stress markers in bipolar disorder,” Psychiatry Research, vol. 218, no. 1-2, pp. 61–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Selek, A. Altindag, G. Saracoglu, and N. Aksoy, “Oxidative markers of Myeloperoxidase and Catalase and their diagnostic performance in bipolar disorder,” Journal of Affective Disorders, vol. 181, pp. 92–95, 2015. View at Publisher · View at Google Scholar
  40. M. Siwek, M. Sowa-Kuaema, D. Dudek et al., “Oxidative stress markers in affective disorders,” Pharmacological Reports, vol. 65, no. 6, pp. 1558–1571, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Alchami, O. O'Donovan, and M. Davies, “PCOS: diagnosis and management of related infertility,” Obstetrics, Gynaecology & Reproductive Medicine, 2015. View at Publisher · View at Google Scholar
  42. N. K. Kuşçu and A. Var, “Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome,” Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 5, pp. 612–617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Sabuncu, H. Vural, M. Harma, and M. Harma, “Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease,” Clinical Biochemistry, vol. 34, no. 5, pp. 407–413, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Liu and D. Zhang, “The role of oxidative stress in the pathogenesis of polycystic ovary syndrome,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 43, no. 2, pp. 187–190, 2012. View at Google Scholar
  45. J. Y. Lee, C. Baw, S. Gupta, N. Aziz, and A. Agarwal, “Role of oxidative stress in polycystic ovary syndrome,” Current Women's Health Reviews, vol. 6, no. 2, pp. 96–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Vague, “The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease,” The American Journal of Clinical Nutrition, vol. 4, no. 1, pp. 20–34, 1956. View at Google Scholar · View at Scopus
  47. W. A. March, V. M. Moore, K. J. Willson, D. I. W. Phillips, R. J. Norman, and M. J. Davies, “The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria,” Human Reproduction, vol. 25, no. 2, pp. 544–551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Giorgino, L. Laviola, and J. W. Eriksson, “Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies,” Acta Physiologica Scandinavica, vol. 183, no. 1, pp. 13–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. K. J. Ellis, “Selected body composition methods can be used in field studies,” Journal of Nutrition, vol. 131, no. 5, 2001. View at Google Scholar · View at Scopus
  50. A. Gambineri, C. Pelusi, V. Vicennati, U. Pagotto, and R. Pasquali, “Obesity and the polycystic ovary syndrome,” International Journal of Obesity, vol. 26, no. 7, pp. 883–896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Kirchengast and J. Huber, “Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome,” Human Reproduction, vol. 16, no. 6, pp. 1255–1260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Holguin and A. Fitzpatrick, “Obesity, asthma, and oxidative stress,” Journal of Applied Physiology, vol. 108, no. 3, pp. 754–759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. H. D. Choi, J. H. Kim, M. J. Chang, Y. Kyu-Youn, and W. G. Shin, “Effects of astaxanthin on oxidative stress in overweight and obese adults,” Phytotherapy Research, vol. 25, no. 12, pp. 1813–1818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. D. Dobrian, M. J. Davies, S. D. Schriver, T. J. Lauterio, and R. L. Prewitt, “Oxidative stress in a rat model of obesity-induced hypertension,” Hypertension, vol. 37, no. 2, pp. 554–560, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Ozata, M. Mergen, C. Oktenli et al., “Increased oxidative stress and hypozincemia in male obesity,” Clinical Biochemistry, vol. 35, no. 8, pp. 627–631, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Couillard, G. Ruel, W. R. Archer et al., “Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6454–6459, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. N. I. Khan, L. Naz, and G. Yasmeen, “Obesity: an independent risk factor for systemic oxidative stress,” Pakistan Journal of Pharmaceutical Sciences, vol. 19, no. 1, pp. 62–65, 2006. View at Google Scholar · View at Scopus
  59. J. Bausenwein, H. Serke, K. Eberle et al., “Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women,” Molecular Human Reproduction, vol. 16, no. 2, pp. 117–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. S. K. Kumanyika, “The obesity epidemic: looking in the mirror,” American Journal of Epidemiology, vol. 166, no. 3, pp. 243–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Chen, W. M. Xu, and D. Zhang, “Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 102, no. 4, pp. 1167–1174, 2014. View at Google Scholar
  62. M. M. Lasram, I. B. Dhouib, A. Annabi, S. El Fazaa, and N. Gharbi, “A review on the molecular mechanisms involved in insulin resistance induced by organophosphorus pesticides,” Toxicology, vol. 322, pp. 1–13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Salvadó, X. Palomer, E. Barroso, and M. Vázquez-Carrera, “Targeting endoplasmic reticulum stress in insulin resistance,” Trends in Endocrinology & Metabolism, vol. 26, no. 8, pp. 438–448, 2015. View at Publisher · View at Google Scholar
  64. X. Chen, D. Yang, L. Li, S. Feng, and L. Wang, “Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome,” Human Reproduction, vol. 21, no. 8, pp. 2027–2032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. I. Singh, A. L. Carey, N. Watson, M. A. Febbraio, and J. A. Hawley, “Oxidative stress-induced insulin resistance in skeletal muscle cells is ameliorated by gamma-tocopherol treatment,” European Journal of Nutrition, vol. 47, no. 7, pp. 387–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Carmina, T. Koyama, L. Chang, F. Z. Stanczyk, and R. A. Lobo, “Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?” American Journal of Obstetrics and Gynecology, vol. 167, no. 6, pp. 1807–1812, 1992. View at Publisher · View at Google Scholar · View at Scopus
  67. R. S. Legro, D. Finegood, and A. Dunaif, “A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2694–2698, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. I. V. Fenkci, M. Serteser, S. Fenkci, and S. Kose, “Paraoxonase levels in women with polycystic ovary syndrome,” The Journal of Reproductive Medicine, vol. 52, no. 10, pp. 879–883, 2007. View at Google Scholar · View at Scopus
  69. A. M. Mohamadin, F. A. Habib, and T. F. Elahi, “Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome,” Pathophysiology, vol. 17, no. 3, pp. 189–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Bloch-Damti and N. Bashan, “Proposed mechanisms for the induction of insulin resistance by oxidative stress,” Antioxidants & Redox Signaling, vol. 7, no. 11-12, pp. 1553–1567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Z. Fardoun, “The use of vitamin E in type 2 diabetes mellitus,” Clinical and Experimental Hypertension, vol. 29, no. 3, pp. 135–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. D. Ren, Y. Hu, Y. Luo, and X. Yang, “Selenium-containing polysaccharides from Ziyang green tea ameliorate high-fructose diet induced insulin resistance and hepatic oxidative stress in mice,” Food & Function, 2015. View at Publisher · View at Google Scholar
  73. J. P. Dias, S. Talbot, J. Sénécal, P. Carayon, and R. Couture, “Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications,” PLoS ONE, vol. 5, no. 9, Article ID e12622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. M. C. Castro, M. L. Massa, L. G. Arbeláez, G. Schinella, J. J. Gagliardino, and F. Francini, “Fructose-induced inflammation, insulin resistance and oxidative stress: a liver pathological triad effectively disrupted by lipoic acid,” Life Sciences, vol. 137, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  75. M.-M. Huber-Buchholz, D. G. P. Carey, and R. J. Norman, “Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 4, pp. 1470–1474, 1999. View at Google Scholar · View at Scopus
  76. N. X. Wen, “Adiponectin and insulin resistance, oxidative stress and movement,” Journal of New Medicine, vol. 40, no. 12, pp. 831–834, 2009 (Chinese). View at Google Scholar
  77. B. A. Maddux, W. See, J. C. Lawrence Jr., A. L. Goldfine, I. D. Goldfine, and J. L. Evans, “Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid,” Diabetes, vol. 50, no. 2, pp. 404–410, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Rudich, N. Kozlovsky, R. Potashnik, and N. Bashan, “Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes,” The American Journal of Physiology, vol. 272, no. 5, part 1, pp. E935–E940, 1997. View at Google Scholar · View at Scopus
  79. S. Tangvarasittichai, “Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus,” World Journal of Diabetes, vol. 6, no. 3, pp. 456–480, 2015. View at Publisher · View at Google Scholar
  80. J. Pi, Y. Bai, Q. Zhang et al., “Reactive oxygen species as a signal in glucose-stimulated insulin secretion,” Diabetes, vol. 56, no. 7, pp. 1783–1791, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. R. MacLaren, W. Cui, S. Simard, and K. Cianflone, “Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue,” Journal of Lipid Research, vol. 49, no. 2, pp. 308–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Pollak, “The insulin and insulin-like growth factor receptor family in neoplasia: an update,” Nature Reviews Cancer, vol. 12, no. 3, pp. 159–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Diamanti-Kandarakis and A. Dunaif, “Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications,” Endocrine Reviews, vol. 33, no. 6, pp. 981–1030, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Gao, S. Nong, X. Huang et al., “The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways,” The Journal of Biological Chemistry, vol. 285, no. 39, pp. 29965–29973, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. H. Kamata, S.-I. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin, “Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases,” Cell, vol. 120, no. 5, pp. 649–661, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Hirosumi, G. Tuncman, L. Chang et al., “A central role for JNK in obesity and insulin resistance,” Nature, vol. 420, no. 6913, pp. 333–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. E. Diamanti-Kandarakis and A. G. Papavassiliou, “Molecular mechanisms of insulin resistance in polycystic ovary syndrome,” Trends in Molecular Medicine, vol. 12, no. 7, pp. 324–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Dunaif, K. R. Segal, D. R. Shelley, G. Green, A. Dobrjansky, and T. Licholai, “Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome,” Diabetes, vol. 41, no. 10, pp. 1257–1266, 1992. View at Publisher · View at Google Scholar · View at Scopus
  89. L. E. Fridlyand and L. H. Philipson, “Reactive species and early manifestation of insulin resistance in type 2 diabetes,” Diabetes, Obesity & Metabolism, vol. 8, no. 2, pp. 136–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. K.-M. Seow, C.-C. Juan, Y.-P. Hsu, J.-L. Hwang, L.-W. Huang, and L.-T. Ho, “Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery,” Human Reproduction, vol. 22, no. 4, pp. 1003–1010, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Corbould, Y.-B. Kim, J. F. Youngren et al., “Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 5, pp. E1047–E1054, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. X.-K. Wu, K. Sallinen, L. Anttila et al., “Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls,” Fertility and Sterility, vol. 74, no. 3, pp. 564–572, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. J. L. Evans, B. A. Maddux, and I. D. Goldfine, “The molecular basis for oxidative stress-induced insulin resistance,” Antioxidants and Redox Signaling, vol. 7, no. 7-8, pp. 1040–1052, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. V. Turan, E. D. Sezer, B. Zeybek, and F. Sendag, “Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome,” Journal of Pediatric & Adolescent Gynecology, vol. 28, no. 2, pp. 119–123, 2015. View at Publisher · View at Google Scholar
  95. Z. Kurdoglu, H. Ozkol, Y. Tuluce, and I. Koyuncu, “Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome,” Journal of Endocrinological Investigation, vol. 35, no. 3, pp. 317–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. I. Alanbay, C. M. Ercan, M. Sakinci, H. Coksuer, M. Ozturk, and S. Tapan, “A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity?” Archives of Gynecology & Obstetrics, vol. 286, no. 4, pp. 1065–1071, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. A. G. Kebapcilar, M. G. Tatar, S. H. Ipekci et al., “Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance,” Archives of Gynecology and Obstetrics, vol. 290, no. 6, pp. 1255–1263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Repaci, A. Gambineri, and R. Pasquali, “The role of low-grade inflammation in the polycystic ovary syndrome,” Molecular and Cellular Endocrinology, vol. 335, no. 1, pp. 30–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Diamanti-Kandarakis, T. Paterakis, K. Alexandraki et al., “Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin,” Human Reproduction, vol. 21, no. 6, pp. 1426–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. F. González, “Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction,” Steroids, vol. 77, no. 4, pp. 300–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. F. González, K. S. Nair, J. K. Daniels, E. Basal, J. M. Schimke, and H. E. Blair, “Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 8, pp. 2836–2843, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. F. González, N. S. Rote, J. Minium, and J. P. Kirwan, “Evidence of proatherogenic inflammation in polycystic ovary syndrome,” Metabolism: Clinical & Experimental, vol. 58, no. 7, pp. 954–962, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. R. M. Touyz, “Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II,” Current Opinion in Nephrology and Hypertension, vol. 14, no. 2, pp. 125–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. T. Ishibashi, “Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases,” Current Pharmaceutical Design, vol. 19, no. 35, pp. 6375–6381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Chenevier-Gobeaux, H. Lemarechal, D. Bonnefont-Rousselot, S. Poiraudeau, O. G. Ekindjian, and D. Borderie, “Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: Regulation by interleukin-1β and tumour necrosis factor-α,” Inflammation Research, vol. 55, no. 11, pp. 483–490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. F. González, N. S. Rote, J. Minium, and J. P. Kirwan, “Increased activation of nuclear factor κB triggers inflammation and insulin resistance in polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 4, pp. 1508–1512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Publisher · View at Google Scholar · View at Scopus
  108. K. N. Keane, V. F. Cruzat, R. Carlessi, P. I. de Bittencourt, and P. Newsholme, “Molecular events linking oxidative stress and inflammation to insulin resistance and beta-cell dysfunction,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 181643, 15 pages, 2015. View at Publisher · View at Google Scholar
  109. V. Nisenblat and R. J. Norman, “Androgens and polycystic ovary syndrome,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 3, pp. 224–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. M. E. Solano, V. A. Sander, H. Ho, A. B. Motta, and P. C. Arck, “Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS),” Journal of Reproductive Immunology, vol. 92, no. 1-2, pp. 33–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. G. Masszi, A. Novak, R. Tarszabo et al., “Effects of vitamin D3 derivative—calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model,” Pharmacological Reports, vol. 65, no. 2, pp. 476–483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. A. A. Bremer and W. L. Miller, “The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance,” Fertility and Sterility, vol. 89, no. 5, pp. 1039–1048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. R. L. Barbieri, A. Makris, R. W. Randall, G. Daniels, R. W. Kistner, and K. J. Ryan, “Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism,” The Journal of Clinical Endocrinology & Metabolism, vol. 62, no. 5, pp. 904–910, 1986. View at Publisher · View at Google Scholar · View at Scopus
  114. J. V. Yelich, R. P. Wettemann, T. T. Marston, and L. J. Spicer, “Luteinizing hormone, growth hormone, insulin-like growth factor-I, insulin and metabolites before puberty in heifers fed to gain at two rates,” Domestic Animal Endocrinology, vol. 13, no. 4, pp. 325–338, 1996. View at Publisher · View at Google Scholar · View at Scopus
  115. E. R. Hernandez, C. E. Resnick, W. D. Holtzclaw, D. W. Payne, and E. Y. Adashi, “Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular mechanism(s) underlying physiological and pharmacological hormonal actions,” Endocrinology, vol. 122, no. 5, pp. 2034–2043, 1988. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Y. Adashi, A. J. W. Hsueh, and S. S. C. Yen, “Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells,” Endocrinology, vol. 108, no. 4, pp. 1441–1449, 1981. View at Publisher · View at Google Scholar · View at Scopus
  117. R. Soldani, A. Cagnacci, and S. S. C. Yen, “Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro,” European Journal of Endocrinology, vol. 131, no. 6, pp. 641–645, 1994. View at Publisher · View at Google Scholar · View at Scopus
  118. J. E. Nestler, L. P. Powers, D. W. Matt et al., “A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 1, pp. 83–89, 1991. View at Publisher · View at Google Scholar · View at Scopus
  119. A.-M. Suikkari, V. A. Koivisto, E.-M. Rutanen, H. Yki-Jarvinen, S.-L. Karonen, and M. Seppala, “Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein,” Journal of Clinical Endocrinology and Metabolism, vol. 66, no. 2, pp. 266–272, 1988. View at Publisher · View at Google Scholar · View at Scopus
  120. P. D. K. Lee, C. A. Conover, and D. R. Powell, “Regulation and function of insulin-like growth factor-binding protein-1,” Proceedings of the Society for Experimental Biology and Medicine, vol. 204, no. 1, pp. 4–29, 1993. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Dunkel, R. Sorva, and R. Voutilainen, “Low levels of sex hormone-binding globulin in obese children,” The Journal of Pediatrics, vol. 107, no. 1, pp. 95–97, 1985. View at Publisher · View at Google Scholar · View at Scopus
  122. L. Ibáñez, N. Potau, M. Zampolli, S. Riqué, P. Saenger, and A. Carrascosa, “Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 7, pp. 2283–2288, 1997. View at Publisher · View at Google Scholar · View at Scopus
  123. D. LeRoith and C. T. Roberts, “Insulin-like growth factors,” Annals of the New York Academy of Sciences, vol. 692, pp. 1–9, 1993. View at Google Scholar
  124. F. González, J. Minium, N. S. Rote, and J. P. Kirwan, “Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 9, pp. 5336–5342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. Y. Yang, J. Qiao, R. Li, and M.-Z. Li, “Is interleukin-18 associated with polycystic ovary syndrome?” Reproductive Biology and Endocrinology, vol. 9, no. 1, article 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Yilmaz, N. Bukan, G. Ayvaz et al., “The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome,” Human Reproduction, vol. 20, no. 12, pp. 3333–3340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. P. R. Piotrowski, J. Kwintkiewicz, and A. Duleba, “Oxidative stress induces expression of CYP11A, CYP17, star and 3 beta HSD in rat theca-interstitial cells,” Journal of the Society for Gynecologic Investigation, vol. 12, no. 2, Article ID 319A-A, 2005. View at Google Scholar
  128. R. Z. Spaczynski, A. Arici, and A. J. Duleba, “Tumor necrosis factor-α stimulates proliferation of rat ovarian theca- interstitial cells,” Biology of Reproduction, vol. 61, no. 4, pp. 993–998, 1999. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Nikolić, D. Macut, A. Djordjevic et al., “Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue,” Molecular and Cellular Endocrinology, vol. 399, pp. 22–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Tepavčević, D. Milutinović, D. Macut et al., “Cardiac nitric oxide synthases and Na+/K+-ATPase in the rat model of polycystic ovary syndrome induced by dihydrotestosterone,” Experimental and Clinical Endocrinology & Diabetes, vol. 123, no. 5, pp. 303–307, 2015. View at Publisher · View at Google Scholar
  131. Y. H. Zheng, T. Ding, D. F. Ye, H. Liu, M. H. Lai, and H. X. Ma, “Effect of low-frequency electroacupuncture intervention on oxidative stress and glucose metabolism in rats with polycystic ovary syndrome,” Acupuncture Research, vol. 40, no. 2, pp. 125–130, 2015. View at Google Scholar
  132. T. Zhang, X. Zou, S. Su, T. Li, J. Wan, and J. Gu, “Effects of visfatin and metformin on insulin resistance and reproductive endocrine in rats with polycystic ovary syndrome,” Journal of Southern Medical University, vol. 34, no. 9, pp. 1314–1318, 2014. View at Google Scholar
  133. F. González, K. S. Nair, J. K. Daniels, E. Basal, and J. M. Schimke, “Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women,” American Journal of Physiology—Endocrinology and Metabolism, vol. 302, no. 3, pp. E297–E306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. F. González, K. S. Nair, J. K. Daniels, E. Basal, J. M. Schimke, and H. E. Blair, “Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 8, pp. 2836–2843, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. J. P. Lu, L. Monardo, I. Bryskin et al., “Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 1, pp. 39–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. L. C. Su, The effects and mechanisms of testosterone on inflammatory factors and insulin sensitivity in 3T3 cells [Ph.D. thesis], Fudan University, Shanghai, China, 2009.
  137. F. González, C. L. Sia, F. Z. Stanczyk, H. E. Blair, and M. E. Krupa, “Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome,” Endocrine, vol. 42, no. 3, pp. 726–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. X. Xu, G. de Pergola, and P. Björntorp, “The effects of androgens on the regulation of lipolysis in adipose precursor cells,” Endocrinology, vol. 126, no. 2, pp. 1229–1234, 1990. View at Publisher · View at Google Scholar · View at Scopus
  139. H. Wahrenberg, I. Ek, S. Reynisdottir, K. Carlström, A. Bergqvist, and P. Arner, “Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 6, pp. 2182–2187, 1999. View at Google Scholar · View at Scopus
  140. T. Kajihara, H. Tochigi, J. Prechapanich et al., “Androgen signaling in decidualizing human endometrial stromal cells enhances resistance to oxidative stress,” Fertility & Sterility, vol. 97, no. 1, pp. 185–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. P. Spritzer, D. Morsch, and D. Wiltgen, “Polycystic ovary syndrome associated neoplasms,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 49, no. 5, pp. 805–810, 2005. View at Google Scholar
  142. J. M. Schildkraut, P. J. Schwingl, E. Bastos, A. Evanoff, C. Hughes, and J. P. Curtin, “Epithelial ovarian cancer risk among women with polycystic ovary syndrome,” Obstetrics & Gynecology, vol. 88, no. 4, part 1, pp. 554–559, 1996. View at Publisher · View at Google Scholar · View at Scopus
  143. Z. Haoula, M. Salman, and W. Atiomo, “Evaluating the association between endometrial cancer and polycystic ovary syndrome,” Human Reproduction, vol. 27, no. 5, pp. 1327–1331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. K. L. Hoyt and M. C. Schmidt, “Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment,” Clinical Laboratory Science, vol. 17, no. 3, pp. 155–163, 2004. View at Google Scholar · View at Scopus
  145. B. G. Chittenden, G. Fullerton, A. Maheshwari, and S. Bhattacharya, “Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review,” Reproductive Biomedicine Online, vol. 19, no. 3, pp. 398–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. S. Papaioannou and J. Tzafettas, “Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 24, no. 1, pp. 19–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. E. J. Fearnley, L. Marquart, A. B. Spurdle, P. Weinstein, and P. M. Webb, “Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study,” Cancer Causes and Control, vol. 21, no. 12, pp. 2303–2308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, “Consensus on women's health aspects of polycystic ovary syndrome (PCOS),” Human Reproduction, vol. 27, no. 1, pp. 14–24, 2012. View at Publisher · View at Google Scholar
  149. S. Kawanishi, Y. Hiraku, S. Pinlaor, and N. Ma, “Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis,” Biological Chemistry, vol. 387, no. 4, pp. 365–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  150. T. P. Szatrowski and C. F. Nathan, “Production of large amounts of hydrogen peroxide by human tumor cells,” Cancer Research, vol. 51, no. 3, pp. 794–798, 1991. View at Google Scholar · View at Scopus
  151. T. B. Kryston, A. B. Georgiev, P. Pissis, and A. G. Georgakilas, “Role of oxidative stress and DNA damage in human carcinogenesis,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 711, no. 1-2, pp. 193–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. M. J. Hoffmann and W. A. Schulz, “Causes and consequences of DNA hypomethylation in human cancer,” Biochemistry and Cell Biology, vol. 83, no. 3, pp. 296–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. K. Wimmer, X.-X. Zhu, J. M. Rouillard et al., “Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma,” Genes Chromosomes & Cancer, vol. 33, no. 3, pp. 285–294, 2002. View at Publisher · View at Google Scholar · View at Scopus
  154. L. Van De Voorde, R. Speeckaert, D. Van Gestel et al., “DNA methylation-based biomarkers in serum of patients with breast cancer,” Mutation Research, vol. 751, no. 2, pp. 304–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. J. M. Ordovás and C. E. Smith, “Epigenetics and cardiovascular disease,” Nature Reviews Cardiology, vol. 7, no. 9, pp. 510–519, 2010. View at Publisher · View at Google Scholar · View at Scopus
  156. F. M. Selaru, S. David, S. J. Meltzer, and J. P. Hamilton, “Epigenetic events in gastrointestinal cancer,” The American Journal of Gastroenterology, vol. 104, no. 8, pp. 1910–1912, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. S.-O. Lim, J.-M. Gu, M. S. Kim et al., “Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter,” Gastroenterology, vol. 135, no. 6, pp. 2128–2140.e8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  158. M. L. N. Deepika, S. Nalini, G. Maruthi et al., “Analysis of oxidative stress status through MN test and serum MDA levels in PCOS women,” Pakistan Journal of Biological Sciences, vol. 17, no. 4, pp. 574–577, 2014. View at Publisher · View at Google Scholar · View at Scopus
  159. L. J. Moran, M. Noakes, P. M. Clifton, R. J. Norman, and M. F. Fenech, “Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 639, no. 1-2, pp. 55–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. Z. Hamurcu, F. Bayram, G. Kahriman, H. Dönmez-Altuntas, and G. Baskol, “Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome,” Gynecological Endocrinology, vol. 26, no. 8, pp. 590–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  161. A. Nersesyan and N. Chobanyan, “Micronuclei and other nuclear anomalies levels in exfoliated buccal cells and DNA damage in leukocytes of patients with polycystic ovary syndrome,” Journal of BUON, vol. 15, no. 2, pp. 337–339, 2010. View at Google Scholar
  162. Y. Dincer, T. Akcay, T. Erdem, E. Ilker Saygili, and S. Gundogdu, “DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 65, no. 8, pp. 721–728, 2005. View at Publisher · View at Google Scholar · View at Scopus
  163. S.-H. Lee, D.-J. Chung, H.-S. Lee et al., “Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome,” Metabolism: Clinical and Experimental, vol. 60, no. 12, pp. 1677–1682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. V. E. Von Gruenigen, K. M. Gil, H. E. Frasure, E. L. Jenison, and M. P. Hopkins, “The impact of obesity and age on quality of life in gynecologic surgery,” American Journal of Obstetrics & Gynecology, vol. 193, no. 4, pp. 1369–1375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. L. J. Schouten, R. A. Goldbohm, and P. A. van den Brandt, “Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study,” International Journal of Gynecological Cancer, vol. 16, supplement s2, p. 492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  167. L. Sjöström, K. Narbro, C. D. Sjöström et al., “Effects of bariatric surgery on mortality in Swedish obese subjects,” The New England Journal of Medicine, vol. 357, no. 8, pp. 741–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  168. M. Nagamani, E. V. Hannigan, T. Van Dinh, and C. A. Stuart, “Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 1, pp. 144–148, 1988. View at Publisher · View at Google Scholar · View at Scopus
  169. Y. Zhang, The research on correlations between endometrial disorders and PI3K/AKT, MAPK/ERK pathways activated by insulin in women with PCOS [M.S. thesis], Tianjin Medical University, 2009.
  170. R. B. Lathi, A. P. Hess, S. Tulac, N. R. Nayak, M. Conti, and L. C. Giudice, “Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1599–1606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. L. C. Giudice, “Endometrium in PCOS: implantation and predisposition to endocrine CA,” Best Practice and Research: Clinical Endocrinology & Metabolism, vol. 20, no. 2, pp. 235–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. B. K. Tan, R. Adya, J. Chen, H. Lehnert, L. J. Sant Cassia, and H. S. Randeva, “Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 3, pp. 808–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  173. M. O. Goodarzi, D. A. Dumesic, G. Chazenbalk, and R. Azziz, “Polycystic ovary syndrome: etiology, pathogenesis and diagnosis,” Nature Reviews Endocrinology, vol. 7, no. 4, pp. 219–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. N. Potischman, R. N. Hoover, L. A. Brinton et al., “Case-control study of endogenous steroid hormones and endometrial cancer,” Journal of the National Cancer Institute, vol. 88, no. 16, pp. 1127–1135, 1996. View at Publisher · View at Google Scholar · View at Scopus
  175. K. Ito, H. Utsunomiya, N. Yaegashi, and H. Sasano, “Biological roles of estrogen and progesterone in human endometrial carcinoma—new developments in potential endocrine therapy for endometrial cancer,” Endocrine Journal, vol. 54, no. 5, pp. 667–679, 2008. View at Publisher · View at Google Scholar · View at Scopus
  176. J. V. Lacey Jr., O. B. Ioffe, B. M. Ronnett et al., “Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan,” British Journal of Cancer, vol. 98, no. 1, pp. 45–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  177. E. Diamanti-Kandarakis, A. Piouka, S. Livadas et al., “Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome,” European Journal of Endocrinology, vol. 204, no. 5, pp. 847–853, 2009. View at Google Scholar
  178. D. Zhang, W.-Y. Luo, H. Liao, C.-F. Wang, and Y. Sun, “The effects of oxidative stress to PCOS,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 39, no. 3, pp. 421–423, 2008. View at Google Scholar · View at Scopus
  179. F. Bayram, D. Kocer, M. Ozsan, and S. Muhtaroglu, “Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction,” Gynecological Endocrinology, vol. 28, no. 7, pp. 497–501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  180. V. M. Victor, M. Rocha, C. Bañuls et al., “Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 10, pp. 3115–3122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  181. Y. Enli, S. M. Fenkci, V. Fenkci, and O. Oztekin, “Serum fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome,” Gynecological Endocrinology, vol. 29, no. 12, pp. 1036–1039, 2013. View at Publisher · View at Google Scholar · View at Scopus
  182. N. U. Sumithra, R. L. Lakshmi, N. L. Menon, K. N. Subhakumari, and V. S. Sheejamol, “Evaluation of oxidative stress and hsCRP in polycystic ovarian syndrome in a tertiary care hospital,” Indian Journal of Clinical Biochemistry, vol. 30, no. 2, pp. 161–166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  183. P. Fan, H. Liu, Y. Wang, F. Zhang, and H. Bai, “Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS,” Reproductive BioMedicine Online, vol. 24, no. 2, pp. 197–205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  184. G. Baskol, E. Aygen, F. Erdem et al., “Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome,” Acta Obstetricia et Gynecologica Scandinavica, vol. 91, no. 3, pp. 326–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. H. Sova, L. Morin-Papunen, U. Puistola, and P. Karihtala, “Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 94, no. 7, pp. 2670–2673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  186. R. Chattopadhayay, A. Ganesh, J. Samanta, S. K. Jana, B. N. Chakravarty, and K. Chaudhury, “Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome,” Gynecologic and Obstetric Investigation, vol. 69, no. 3, pp. 197–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  187. V. Fenkci, S. Fenkci, M. Yilmazer, and M. Serteser, “Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease,” Fertility and Sterility, vol. 80, no. 1, pp. 123–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  188. N. B. Karuputhula, R. Chattopadhyay, B. Chakravarty, and K. Chaudhury, “Oxidative status in granulosa cells of infertile women undergoing IVF,” Systems Biology in Reproductive Medicine, vol. 59, no. 2, pp. 91–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  189. F. González, N. S. Rote, J. Minium, and J. P. Kirwan, “Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 1, pp. 336–340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  190. N. Hilali, M. Vural, H. Camuzcuoglu, A. Camuzcuoglu, and N. Aksoy, “Increased prolidase activity and oxidative stress in PCOS,” Clinical Endocrinology, vol. 79, no. 1, pp. 105–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  191. F. F. Verit and O. Erel, “Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters,” Gynecologic and Obstetric Investigation, vol. 65, no. 4, pp. 233–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  192. D. MacUt, T. Simic, A. Lissounov et al., “Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress,” Experimental and Clinical Endocrinology & Diabetes, vol. 119, no. 7, pp. 451–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  193. I. Alanbay, C. Mutlu Ercan, H. Coksuer et al., “Neopterin: a promising marker for the inflammation in polycystic ovary syndrome,” Gynecological Endocrinology, vol. 28, no. 11, pp. 879–883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  194. A. K. Seleem, A. A. El Refaeey, D. Shaalan, Y. Sherbiny, and A. Badawy, “Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection,” Journal of Assisted Reproduction and Genetics, vol. 31, no. 4, pp. 499–504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  195. H. Gao, J. Meng, H. Xing et al., “Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women,” Human Reproduction, vol. 29, no. 5, pp. 1058–1066, 2014. View at Publisher · View at Google Scholar · View at Scopus
  196. S. M. Fenkci, V. Fenkci, O. Oztekin, S. Rota, and N. Karagenc, “Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome,” Human Reproduction, vol. 23, no. 7, pp. 1602–1606, 2008. View at Publisher · View at Google Scholar · View at Scopus